GLP-1 Drug Boom Could Cut Food Freight Demand by 3 Million Loads Yearly

Key Details GLP-1 medications like Ozempic and Wegovy are reshaping freight demand in unexpected ways. With roughly 12% of U.S. adults using these appetite-suppressing drugs, early research from Purdue and Cornell suggests a 3% drop in total food and beverage caloric demand. Applied to the 100+ million food truckloads moved annually, this translates to approximately 3 million fewer loads per year. Why It Matters This disruption rivals major industry consolidation moves - the proposed Union Pacific-Norfolk Southern merger is only projected to divert around 2 million truckloads through improved rail efficiency. GLP-1 adoption is already matching that impact while still in early penetration stages. Snack and beverage categories face the hardest hits, particularly beer and processed foods. Market Signals Brokers report softening demand in reefer and dry van segments for consumer packaged goods. Fresh produce and proteins show relative resilience as consumers shift toward nutrient-dense options while eating less overall. Real-world freight data is beginning to confirm the trend beyond theoretical projections. What's Next As GLP-1 medication adoption continues climbing, food and beverage freight lanes will likely face sustained pressure. Drivers and carriers should monitor CPG freight patterns closely and consider diversifying beyond traditional snack-heavy routes.